CJC-1295 + IPAMORELIN
Product Overview
CJC-1295 and Ipamorelin are frequently paired in research due to their complementary mechanisms of action within the growth hormone (GH) axis. Together, they provide a coordinated approach to stimulating endogenous GH release through both hypothalamic and pituitary signaling pathways.
CJC-1295, a growth hormone releasing hormone (GHRH) analog, works by promoting sustained stimulation of GH release, while Ipamorelin, a selective growth hormone secretagogue, triggers pulsatile GH secretion through ghrelin receptor activation. The combination allows researchers to investigate both sustained and episodic GH signaling within a single model.
This dual-pathway approach makes the blend a widely used option in studies focused on recovery signaling, endocrine balance, and the relationship between growth hormone activity and metabolic processes.
Mechanism of Action
This combination targets two complementary pathways:
CJC-1295 (GHRH analog)Stimulates the pituitary to increase growth hormone output over an extended duration
Ipamorelin (Ghrelin receptor agonist)Promotes pulsatile growth hormone release via selective receptor activation
Together, these mechanisms enable a more complete model for studying growth hormone dynamics and downstream signaling effects.
Key Research Applications
Growth hormone axis stimulation and modeling
Recovery and repair pathway research
Endocrine system regulation studies
Sleep and circadian hormone rhythm research
Body composition and metabolic signaling
Product Specifications
Total Quantity: 10mg (combined blend)
Form: Lyophilized powder
Purity: ≥98% (HPLC tested)
Appearance: White to off-white powder
Storage:
Long-term: -20°C
Short-term (reconstituted): 2–8°C
Reconstitution Guidance (General Laboratory Use)
This product is supplied in lyophilized form and requires reconstitution prior to use.
Use sterile bacteriostatic water
Introduce solution slowly along the vial wall
Gently swirl—do not shake
Final concentration and protocol should be adjusted based on specific research requirements.
Quality Assurance
Third-party tested for purity and identity
Batch-specific Certificate of Analysis (COA) available
Manufactured in controlled laboratory environments
What’s Included
1 × 10mg CJC-1295 + Ipamorelin blend vial
COA access for batch verification
Research Use Notice
For research use only. Not intended for human consumption.
